Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00731380
What this trial is testing

A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University Health Network, Toronto 12
Not applicableWithdrawnNCT05222308
What this trial is testing

Advanced Planning for Online Accounts and Data

Who this might be right for
Terminal CancerMetastatic Cancer
University of Colorado, Denver
Early research (Phase 1)Study completedNCT00037817
What this trial is testing

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Who this might be right for
Advanced Esophageal CancersPrimary Small Cell Lung CancersNon-Small-Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00081289
What this trial is testing

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Radiation Therapy Oncology Group 146
Testing effectiveness (Phase 2)Study completedNCT01328574
What this trial is testing

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUreteral NeoplasmsUreter Cancer+2 more
National Cancer Institute (NCI) 13
Early research (Phase 1)Looking for participantsNCT07018518
What this trial is testing

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAdult
Chinese PLA General Hospital 25
Early research (Phase 1)Looking for participantsNCT05877924
What this trial is testing

NBL-020 Injection in Subjects With Advanced Malignant Tumors.

Who this might be right for
Advanced Malignant Tumors
NovaRock Biotherapeutics, Ltd 200
Early research (Phase 1)Looking for participantsNCT06426680
What this trial is testing

The ILB-3101 in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Innolake Biopharm 240
Not applicableLooking for participantsNCT06073938
What this trial is testing

Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement

Who this might be right for
Advanced Solid Tumors or Lymphomas
Hunan Province Tumor Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02031458
What this trial is testing

Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 667
Testing effectiveness (Phase 2)Study completedNCT00541008
What this trial is testing

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
UNICANCER 92
Testing effectiveness (Phase 2)WithdrawnNCT03644589
What this trial is testing

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMetastatic Breast Cancer+3 more
University of Washington
Large-scale testing (Phase 3)Looking for participantsNCT06964568
What this trial is testing

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Who this might be right for
Esophageal CarcinomaRadiotherapyImmunotherapy
Fudan University 452
Not applicableApproved For MarketingNCT01160250
What this trial is testing

Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Genentech, Inc.
Not applicableLooking for participantsNCT06945718
What this trial is testing

Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30)

Who this might be right for
Gastric CancerSurgery
Fujian Medical University 760
Large-scale testing (Phase 3)WithdrawnNCT00349518
What this trial is testing

Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT02319824
What this trial is testing

NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy

Who this might be right for
Sarcoma
Fred Hutchinson Cancer Center 2
Early research (Phase 1)Study completedNCT01139723
What this trial is testing

The Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors

Who this might be right for
Solid Cancers
Genentech, Inc. 54
Not applicableStudy completedNCT05022823
What this trial is testing

Exercise and Compression for Lymphedema

Who this might be right for
Breast Cancer Related Lymphedema
AHS Cancer Control Alberta 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07343479
What this trial is testing

Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)EGFR Gene MutationsBrain Metastasis
Zhejiang Cancer Hospital 45
Next Page